Notícias · Recifes

Gut microbiota can predict risk of type 2 diabetes years before it develops

The presence of certain bacteria in the gut microbiota, and fluctuations in a person's metabolism, can be seen in people who go on to develop type 2 diabetes years later. This has been shown in a large Swedish study led by researchers at Chalmers University of Technology. The stu

Admin Recifes 15/07/2026 2

First AI agent and risk prediction model for precision diabetes management

A research team at The Hong Kong Polytechnic University (PolyU) has developed Hong Kong's first "AI Agent for Precision Diabetes Management—PIPE-AI" (AI Agent), designed specifically for Asian populations, together with a related disease risk prediction model. Leveraging artifici

Admin Recifes 15/07/2026 2

Largest study yet reveals which cancers have their own microbiomes

For decades, cancer has been thought of as a purely human disease—rogue cells multiplying out of control, with no room for anything else in the picture. But a growing body of research suggests that isn't quite right. Some tumors, it turns out, come with company: communities of ba

Admin Recifes 15/07/2026 2

New comprehensive data platform could transform Alzheimer's research, treatment

With an increasingly aging global population and no available preventive treatments, Alzheimer's disease and related dementias are poised to become an even larger public health challenge. The mechanisms underlying Alzheimer's disease are difficult to study because the disease has

Admin Recifes 15/07/2026 2

Kidney disease profile shifts: Diabetes-linked CKD rises as overall US rate stalls

Chronic kidney disease (CKD) is common, largely silent and serious. Most people who have the condition do not realize they have it, while it sharply raises the risk of heart attacks, strokes, kidney failure and early death. Over the past decade, the share of American adults livin

Admin Recifes 15/07/2026 2

One-size-fits-all fetal growth charts often fail to spot at-risk babies, large study finds

One-size-fits-all fetal growth charts used in the NHS to monitor babies' growth before birth often misclassify babies as being either too small or too large, which can lead to missed cases at risk of stillbirth or unnecessary interventions, finds a study of more than 3 million NH

Admin Recifes 15/07/2026 3

Commonly used drugs show small benefit for long COVID fatigue

Over-the-counter antihistamines and a prescription anti-inflammatory drug both have a small benefit in reducing long COVID fatigue among people receiving care from specialist long COVID clinics, according to new findings from a large clinical trial led by UCL and UCLH.

Admin Recifes 15/07/2026 2

Medical AI may look less biased on paper but not in practice, new study finds

Large language models (LLMs) are only as good as the data they learn from. If their training data contains social biases, the models may unintentionally repeat those biases in their responses. As their use increases with the rise of generative AI, it has become evident that they

Admin Recifes 15/07/2026 2

Proportion of ED visits for suspected suicide down from 2021 to 2025

From 2021 to 2025, the overall proportion of emergency department (ED) visits for suspected suicide attempts among all ED visits for any reason decreased, with the largest declines seen among adolescents and females, according to research published in the U.S. Centers for Disease

Admin Recifes 15/07/2026 2

Losing sleep is bad for individuals. Communities, too?

Large groups of people often lose sleep because of big events like a record 18-inning World Series game or a contested election night, or sudden crises like a flood, pandemic or war. In a new paper published in Clocks & Sleep, Harvard sleep researchers argue that while the mental

Admin Recifes 15/07/2026 2

Meningococcal B vaccine ineffective in gonorrhea prevention for men who have sex with men

The meningococcal B vaccine is ineffective in gonorrhea prevention among men who have sex with men (MSM) at high risk of infection, according to findings from the world's largest randomized controlled trial (RCT) into possible efficacy published in the New England Journal of Medi

Admin Recifes 15/07/2026 2

Many chronic pain patients can reduce opioid use with slow, voluntary taper

More than 50 million Americans live with chronic pain; among them, approximately 1 in 10 take prescription opioids regularly. A new large-scale study led by Stanford Medicine suggests that—with the right approach—many people may be able to reduce their opioid use long term withou

Admin Recifes 15/07/2026 2

Acompanhe as Notícias da Recifes